US2006122371A1PendingUtilityA1

Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same

Assignee: PHARIS BIOTEC GMBHPriority: Jun 2, 1994Filed: Mar 21, 2005Published: Jun 8, 2006
Est. expiryJun 2, 2014(expired)· nominal 20-yr term from priority
A61P 7/10C07K 14/58A61K 38/00
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a process for the preparation of cardiodilatin fragments, to highly purified cardiodilatin fragments, and to appropriate intermediates for the preparation of said fragments. Furthermore, the invention relates to highly purified cardiodilatin fragments which are free of peptide impurities and exhibit a single migration peak in capillary electrophoresis, as well as to appropriate processes for the preparation of same.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled)  
     
     
         21 . A fragment of ANP (95-126) selected from the group consisting of: 
 (a) Boc-Thr(tBu)-Ala-Pro-Arg(Pbf)-Ser(tBu)-Leu-Arg(Pbf)-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Cys(Acm)-Phe-Gly-Gly-OH (SEQ ID 6);    (b) Fmoc-Arg(Pbf)-Met-Asp(OtBu)-Arg(Pbf)-Ile-Gly-Ala-Gln(Trt)-Ser(tBu)-Gly-Leu-Gly-OH (SEQ ID 7);    (c) Fmoc-Cys(Trt)-Asn(Trt)-Ser(tBu)-Phe-Arg(Pbf)-Tyr(tBu)OH (SEQ ID 8);    (d) Fmoc-Cys(Trt)-Asn(Trt)-Ser(tBu)-Phe-Arg(Pbf)-Tyr(tBu)-OtBu (SEQ ID 8);    (e) H-Cys(Trt)-Asn(Trt)-Ser(tBu)-Phe-Arg(Pbf)-Tyr(tBu)-OtBu (SEQ ID 8);    (f) Fmoc-Arg(Pbf)-Met-Asp(Otbu)-Arg(Pbf)-Ile-Gly-Ala-Gln(Trt)-Ser(tBu)-Gly-Leu-Gly-Cys(Trt)-Asn(Trt)-Ser(tBu)-Phe-Arg(Pbf)-Tyr(tBu)-OtBu (SEQ ID 9); and    (g) H-Arg(Pbf)-Met-Asp(Otbu)-Arg(Pbf)-Ile-Gly-Ala-Gln(Trt)-Ser(tBu)-Gly-Leu-Gly-Cys(Trt)-Asn(Trt)-Ser(tBu)-Phe-Arg(Pbf)-Tyr(tBu)-OtBu (SEQ ID 9).    
     
     
         22 . A fragment of ANP (95-126) selected from the group consisting of: 
 (a) Boc-Thr(tBu)-Ala-Pro-Arg(Pbf)-Ser(tBu)-Leu-Arg(Pbf)-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Cys(Acm)-Phe-Gly-Gly-Arg(Pbf)-Met-Asp(OtBu)-Arg(Pbf)-Ile-Gly-Ala-G In (Trt)-Ser(tBu)-Gly-Leu-Gly-Cys(Trt)-Asn(Trt)-Ser(tBu)-Phe-Arg(Pbf)-Tyr(tBu)-OtBu- (SEQ ID 10); and    (b) H-Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys(Acm)-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (SEQ ID 5).    
     
     
         23 . The fragment of  claim 22 , wherein such fragment is stable.

Join the waitlist — get patent alerts

Track US2006122371A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.